Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Rifampicin and clarithromycin (extended release) versus rifampicin and streptomycin for limited Buruli ulcer lesions: a randomised, open-label, non-inferiority phase 3 trial
PaperCitations, authors & open-access status
Rifampicin and clarithromycin (extended release) versus rifampicin and streptomycin for limited Buruli ulcer lesions: a randomised, open-label, non-inferiority phase 3 trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 112 citations, 2020 year and hybrid oa status.
112
Citations
2020
Year
hybrid
OA Status